Canada markets closed

Safeguard Scientifics, Inc. (SFE)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
3.7300+0.1100 (+3.04%)
At close: 04:00PM EDT
3.7300 0.00 (0.00%)
After hours: 04:49PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close3.6200
Open3.7000
Bid1.5000 x 1400
Ask8.6500 x 800
Day's Range3.7100 - 3.8300
52 Week Range3.3200 - 8.8800
Volume21,534
Avg. Volume12,998
Market Cap61.124M
Beta (5Y Monthly)1.05
PE Ratio (TTM)24.87
EPS (TTM)0.1500
Earnings DateNov 02, 2022 - Nov 07, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateDec 20, 2019
1y Target EstN/A
  • GlobeNewswire

    SAFEGUARD SCIENTIFICS ANNOUNCES LUMESIS EXIT

    RADNOR, Pa., Sept. 29, 2022 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NYSE:SFE) (“Safeguard”) today announced the acquisition of Lumesis by SOLVE Advisors, Inc., a market data platform for fixed income securities. Safeguard received $5.3 million of initial cash proceeds. Additional cash proceeds may be received from the final determinations of net working capital and the resolution of various escrow contingencies. Safeguard will report a gain on the sale of the Lumesis ownership interest

  • Thomson Reuters StreetEvents

    Edited Transcript of SFE.N earnings conference call or presentation 11-Aug-22 9:00pm GMT

    Q2 2022 Safeguard Scientifics Inc Earnings Call

  • GlobeNewswire

    Safeguard Scientifics Announces Second Quarter 2022 Financial Results

    Conference call and webcast on August 11, 2022 at 5 p.m. ETRADNOR, Pa., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NYSE:SFE) (“Safeguard” or the “Company”) today announced financial results for the three and six months ended June 30, 2022. SECOND QUARTER 2022 HIGHLIGHTS Safeguard Company Performance Moxe raised $30 million in an equity round to further support its strong growth and expand its clinical data exchange solutions. The new capital reduced Safeguard’s primary owners